secwatch.observer — SEC 8-K summary
======================================

Issuer:     CANNAPHARMARX, INC. (CPMD)
CIK:        0001081938
Form:       8-K
Filed at:   2023-10-13T23:59:59+00:00
Accession:  0001683168-23-007145
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CannaPharmaRX appoints Oliver Foeste as CFO; John Cassels departs without disagreement
--------------------------------------------------------------------------------

- John Cassels replaced as CFO effective Oct 13, 2023; no disagreement with company on operations.
- Oliver Foeste appointed CFO; founder of Invictus Accounting Group, CPA, senior finance roles at TSX, TSXV, NYSE issuers.
- Foeste engaged in July 2023 for backup CFO services; compensation includes annual bonuses/stock options and hourly billing $65-$400.
- No family relationships or material interests between Foeste and any director/officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1081938/000168316823007145/0001683168-23-007145-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1081938/000168316823007145/cannapharmarx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-007145

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer